Drug recall · July 27, 2016
0.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCI recall
Why: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
0.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCI (Preservative Free) in 0.9% Sodium Chloride, 250 mL Hospira LifeCare bag, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-995-54 ,
- Lots / codes
Lot # 160420165M; Exp. 05/16 Lot # 160540128M; Exp. 05/16 Lot # 160630117M; Exp. 06/16 Lot # 160770157M; Exp. 06/16 Lot # 160870055M; Exp. 06/16 Lot # 160890153M; Exp. 06/16 Lot # 160950340M; Exp. 07/16
- Quantity
- 80 bags
- Company
- Pharmedium Services, LLC, Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- May 5, 2016 · Voluntary: Firm initiated
- Classified
- July 16, 2016
- Reported
- July 27, 2016
- Ended
- March 6, 2018
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Morphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.